FORT MYERS, Fla. (AP) — FORT MYERS, Fla. (AP) — NeoGenomics Inc. (NEO) on Tuesday reported a loss of $17.1 million in its first quarter.
On a per-share basis, the Fort Myers, Florida-based company said it had a loss of 13 cents. Earnings, adjusted for stock option expense and amortization costs, were 1 cent per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was breakeven on a per-share basis.
The operator of cancer-focused testing laboratories posted revenue of $186.7 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $184.4 million.
NeoGenomics expects full-year revenue in the range of $797 million to $803 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NEO at https://www.zacks.com/ap/NEO
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
